Investigational Marburg Vaccine Delivered to Ethiopia
The Sabin Vaccine Institute has delivered over 640 doses of its unlicensed cAd3-Marburg vaccine to Ethiopia for a Phase 2 trial amid an outbreak with an 88% fatality rate. Learn about the global response.